NOVABRIDGE BIOSCIENC ADR (NBP) insider trading activity (SEC Form 4). Over the trailing 90 days, NBP insiders filed 0 purchases totalling $0 and 4 sales totalling $66K — net SELLING of $66K. Most recent filing: Jul 7, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Xu Cong Claire | SVP, Clinical Development | S SaleOE | — | $0.89 | $4K | filing |
| Jun 22, 2026 | Dennis Phillip Andrew | Chief Medical Officer | S SaleOE | — | $0.66 | $6K | filing |
| Jun 2, 2026 | Xu Cong Claire | SVP, Clinical Development | S SaleOE | — | $3.94 | $14K | filing |
| May 18, 2026 | Cao Sean Wuxiong | See Remarks | S Sale | — | $1.99 | $43K | filing |